ASHTON NEALY: Open Payments
NPI 1841829405 · NASHVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 11 payments from 3 companies in 2025. Trend: 2023 $595 · 2024 $489 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $287 |
| Teva Pharmaceuticals USA, Inc. | 3 | $165 |
| ABBVIE INC. | 4 | $65 |
Products named: REXULTI, UZEDY, VRAYLAR.
Industry payments across AR — which companies pay providers there.
